Dianthus Therapeutics stockDNTH
Dianthus Therapeutics trades at $83.01, 29.6% below its 52-week high (Aug 19, 2026). The price is below its 50- and 200-day averages, a downtrend. +101.4% year to date, +146.1% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Mar 16, 2027.
Ratings, candles, signals and the screener for DNTH — after you log in
Open the terminalFrequently asked questions about Dianthus Therapeutics
What is the Dianthus Therapeutics stock price?
At the close on Nov 5, 2026: $83.01 (−3.26% on the day). 52-week high: $117.88 on Aug 19, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Dianthus Therapeutics report earnings?
The next quarterly report is on Mar 16, 2027. Last quarter, earnings per share changed +16% year over year, revenue +206%.
Does Dianthus Therapeutics pay dividends?
No, Dianthus Therapeutics does not pay dividends.
Where does Dianthus Therapeutics trade and how to buy it?
Ticker DNTH, exchange Nasdaq, listed since 2018. You can buy it through a broker with access to US exchanges.
Should I buy Dianthus Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for DNTH are in the terminal after you log in.